Featured on: Forbes.com
Publication date: Aug 24, 2009
Publication date: Aug 24, 2009
The allergy medication Xyzal has received FDA approval for the treatment of indoor allergies and hives in children from the age of six months. It had previously been approved only for children aged six years and up. The drug also has FDA clearance for treating outdoor allergies in children aged two and up
More Allergies Asthma Articles
Asthma Coaching Can Reduce Hospitalizations In Some ChildrenFindngs 'could Cut Allergy Deaths'
Hair Dye Allergies Increase
It Takes Cats And Dogs To Stop Allergies
Pediatric Chronic Cough Linked To Reflux And Allergies
Yoga Reduces Asthma Attacks, Says Researchers
5 Ways To Remain Active During Summer Allergy Season
Tips For Dealing With Fall Allergies From DampRid
Selectwisely.com Prevents Allergies From Getting Lost In Translation
Louse Infection Lowers Asthma Risk
